LFVN NASDAQ

Lifevantage Corp

Health Care ·Pharmaceutical preparations ·Common Stock
Dividend per share · FY2026$0.185as reported in the 10-K
FCF cover · FY20262.85x3-year average 2.39x
Consecutive increases1years, within FY2022–FY2026

LFVN dividend record

Annual figures as reported in Lifevantage Corp’s Form 10-K filings with the US SEC. Free cash flow = operating cash flow − capital expenditure. FCF cover = free cash flow ÷ dividends paid. Each row links to its filing. Data as of SEC EDGAR, retrieved 16 Nov 2026.

  • Dividend per share rose in FY2026.
  • Dividend per share fell 70% in FY2025.
  • Dividend per share rose 317% in FY2023 and 336% in FY2024. Large one-year changes can reflect a special dividend, a resumed dividend or a change in payment timing; the 10-K explains which.
  • Dividend per share is the amount paid in each fiscal year, as the company reports it in its 10-K.

Original source: Lifevantage Corp filings on SEC EDGAR · How we calculate · Report an error

General information only — not financial advice. Share prices and dividend yields are not shown until a licensed price feed is connected.

About Lifevantage Corp

Lifevantage Corp is listed on the Nasdaq under the ticker LFVN. The SEC classifies its business as “Pharmaceutical Preparations” (SIC code 2834). Its fiscal year ends in December.

Common Stock 2-3x